Even if diagnostic criteria are well specified in the WHO classification, in clinical practice, distinguishing aCML from the other BCR/ABL1 negative myeloid neoplasms could be challenging. The gene discussed is ABL1; the disease is atypical chronic myeloid leukemia, BCR-ABL1 negative.